How Wellend Health Will Revolutionize Telemedicine in 2015

By Admin
Share
On the south end of Australia sits a company that is driving efforts to end breast cancer and promote overall wellness – all via telemedicine. In...

On the south end of Australia sits a company that is driving efforts to end breast cancer and promote overall wellness – all via telemedicine.

In its newly established e-newsletter titled HOPE, Wellend Health will showcase groundbreaking facts, stories and information on women’s health.

Healthcare Global has reported on how telemedicine is driving change to the industry with major players such as Google entering the field, and Wellend Health is certain to spark change in Australia, as well.

Wellend Health was created to be a “place of wellness, not a place of illness” and the company is focused on “Helping you achieve a foundation of good health; firstly by getting your hormones in balance, and then by helping you incorporate simple and natural solutions into your daily life so that you feel well and stay well.”

These e-newsletters are sure to be a driving force in helping patients incorporate healthy changes into their daily lives. In fact, the company has already begun to make a dent in breast cancer education.

Led by Dr. Stephen Birrell – a highly regarded doctor and scientist who is also co-founder and medical director of the company – Wellend Health has created T+Ai therapy.

The treatment is directed at reducing breast density, which Dr. Birrell discovered to be linked to breast cancer. In T+Ai therapy, a personalized hormone supplement is implanted into the “fat” of the lower abdomen or lower hip that will slowly dissolve over four months.

By making individuals aware of related causes to life-threatening diseases, something as small as an e-newsletter can make all the difference to someone’s life.

To sign up for Wellend Health’s e-newsletter, click here

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma